Anja Vogelmann

2022	PhD thesis, Albert-Ludwigs-University of Freiburg
2019 - 2022	PhD student in the lab of Prof. Dr. Manfred Jung, Institute of Pharmaceutical Sciences (Medicinal Chemistry), University of Freiburg
2018 - 2019	Diploma grade in pharmacy (Dipl. Pharm.), University of Freiburg with research stay at the University of Copenhagen
2018	3rd State-accredited Examination (3. Staatsexamen) and Pharmaceutical License (Approbation)
2017 - 2018	Pharmacist in practical training, Bad Krozingen and Ulm
2017	2nd State-accredited Examination (2. Staatsexamen), Freiburg
2014	1st State-accredited Examination (1. Staatsexamen), Freiburg
2012 - 2017	Studies of Pharmaceutical Sciences at the University of Freiburg

Awards, scholarships

2013	Scholarship “Deutschlandstipendium”

Publications

• Vogelmann A., Schiedel M., Wössner N., Merz A., Herp D., Hammelmann S., Colcerasa A., Komaniecki G., Hong J.Y., Sum M., Metzger E., Neuwirt E., Zhang L., Einsle O., Groß O., Schüle R., Lin H., Sippl W. and Jung M. (2022) Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration. RSC Chemical Biology doi: 10.1039/D1031CB00244A.
• Vogelmann A., Jung M., Hansen F.K. and Schiedel M. (2022) Comparison of Cellular Target Engagement Methods for the Tubulin Deacetylases Sirt2 and HDAC6: NanoBRET, CETSA, Tubulin Acetylation, and PROTACs. ACS Pharmacol Transl Sci 5, 138-140.
• Vogelmann A., Robaa D., Sippl W. and Jung M. (2020) Proteolysis targeting chimeras (PROTACs) for epigenetics research. Curr Opin Chem Biol 57, 8-16.
• Brosowsky J., Lutterbeck M., Liebich A., Keller M., Herp D., Vogelmann A., Jung M. and Breit B. (2020) Syntheses of Thailandepsin B Pseudo-Natural Products: Access to New Highly Potent HDAC Inhibitors via Late-Stage Modification. Chemistry, doi: 10.1002/chem.202002449.